drugset

drugset / Trial / NCT02094885

The Bioseal Vascular Study

NCT02094885 ↗

Phase 4 Completed 252 enrolled Ethicon, Inc. Guangzhou Bioseal Biotechnology Co., Ltd. · collab

RandomizedParallel-groupSingle-blindTreatment

Summary

To evaluate the clinical utility of Bioseal as an adjunct to control bleeding during elective vascular surgery.

Timeline

Start: 2014-02-01
Primary completion: 2014-11-01
Completion: 2014-12-01

Publications

Ma GW, Kucey A, Tyagi SC, Papia G, Kucey DS, Varcoe RL, Forbes T, Neville R, Dueck AD, Kayssi A. The role of sealants for achieving anastomotic hemostasis in vascular surgery. Cochrane Database Syst Rev. 2024 May 2;5(5):CD013421. doi: 10.1002/14651858.CD013421.pub2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bioseal Fibrin Sealant	Protein / enzyme biologic	—	—

Indications